- £16.39m
- £4.38m
- £4.05m
Annual income statement for Parkmead, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.61 | 12.1 | 14.8 | 5.72 | 4.05 |
| Cost of Revenue | |||||
| Gross Profit | 1.77 | 10.8 | 12.5 | 3.42 | 1.87 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 16.4 | 6.92 | 50 | 4.38 | -3.49 |
| Operating Profit | -12.8 | 5.21 | -35.2 | 1.34 | 7.54 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13.4 | 3.96 | -35.3 | 1.07 | 7.47 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -13.8 | -0.814 | -40 | 3.43 | 7.35 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -13.8 | -0.814 | -42.3 | 4.94 | 7.35 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -13.8 | -0.814 | -42.3 | 4.94 | 7.35 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.06 | 0.011 | -0.093 | 0.028 | 0.004 |